BOOSTRIX INJ
₹1,538.00
Boostrix is a Tdap (Tetanus, Diphtheria, and Acellular Pertussis) vaccine developed by GlaxoSmithKline. It’s administered as a 0.5 mL intramuscular injection to boost immunity against these three serious bacterial infections. The vaccine is recommended for individuals aged 10 years and older and is also advised during the third trimester of pregnancy to protect newborns from pertussis.
Description
Boostrix is a combination vaccine that provides protection against:
-
Tetanus (T): A disease caused by a toxin produced by the bacterium Clostridium tetani, leading to muscle stiffness and spasms.
-
Diphtheria (D): A bacterial infection affecting the mucous membranes of the throat and nose, potentially leading to breathing difficulties, heart failure, or death.
-
Pertussis (P): Also known as whooping cough, this highly contagious respiratory disease can be particularly severe in infants and young children.
Indications:
-
Active booster immunization against tetanus, diphtheria, and pertussis in individuals aged 10 years and older.
-
Immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.
Dosage and Administration:
-
Dose: 0.5 mL
-
Route: Intramuscular injection
-
Frequency: Administered as a single dose. Boosters may be given every 10 years or as recommended by a healthcare provider.
Common Side Effects:
-
Pain, redness, or swelling at the injection site
-
Headache
-
Fatigue
-
Fever
-
Nausea, vomiting, or diarrhea
-
Body aches
These side effects are generally mild and resolve within a few days.
Serious Side Effects:
While rare, serious side effects can occur, including:
-
Severe allergic reactions (e.g., anaphylaxis)
-
Seizures
-
Persistent high fever
-
Severe headache or blurred vision
If any of these occur, seek medical attention immediately.
Precautions:
-
Individuals with a history of severe allergic reactions to any component of the vaccine should not receive Boostrix.
-
Consult a healthcare provider if you have a history of seizures, Guillain-Barré syndrome, or other neurological disorders before receiving the vaccine.
Reviews
There are no reviews yet.